32872333|t|Pemafibrate Protects Against Retinal Dysfunction in a Murine Model of Diabetic Retinopathy.
32872333|a|Diabetic retinopathy (DR) is one of the leading causes of blindness globally. Retinal neuronal abnormalities occur in the early stage in DR. Therefore, maintaining retinal neuronal activity in DR may prevent vision loss. Previously, pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, was suggested as a promising drug in hypertriglyceridemia. However, the role of pemafibrate remains obscure in DR. Therefore, we aimed to unravel systemic and retinal changes by pemafibrate in diabetes. Adult mice were intraperitoneally injected with streptozotocin (STZ) to induce diabetes. After STZ injection, diet supplemented with pemafibrate was given to STZ-induced diabetic mice for 12 weeks. During the experiment period, body weight and blood glucose levels were examined. Electroretinography was performed to check the retinal neural function. After sacrifice, the retina, liver, and blood samples were subjected to molecular analyses. We found pemafibrate mildly improved blood glucose level as well as lipid metabolism, boosted liver function, increased serum fibroblast growth factor21 level, restored retinal functional deficits, and increased retinal synaptophysin protein expression in STZ-induced diabetic mice. Our present data suggest a promising pemafibrate therapy for the prevention of early DR by improving systemic metabolism and protecting retinal function.
32872333	0	11	Pemafibrate	Chemical	MESH:C540740
32872333	29	48	Retinal Dysfunction	Disease	MESH:D012164
32872333	54	60	Murine	Species	10090
32872333	70	90	Diabetic Retinopathy	Disease	MESH:D003930
32872333	92	112	Diabetic retinopathy	Disease	MESH:D003930
32872333	114	116	DR	Disease	MESH:D003930
32872333	150	159	blindness	Disease	MESH:D001766
32872333	170	200	Retinal neuronal abnormalities	Disease	MESH:D012173
32872333	229	231	DR	Disease	MESH:D003930
32872333	285	287	DR	Disease	MESH:D003930
32872333	300	311	vision loss	Disease	MESH:D014786
32872333	325	336	pemafibrate	Chemical	MESH:C540740
32872333	356	404	peroxisome proliferator-activated receptor alpha	Gene	19013
32872333	453	473	hypertriglyceridemia	Disease	MESH:D015228
32872333	496	507	pemafibrate	Chemical	MESH:C540740
32872333	527	529	DR	Disease	MESH:D003930
32872333	594	605	pemafibrate	Chemical	MESH:C540740
32872333	609	617	diabetes	Disease	MESH:D003920
32872333	625	629	mice	Species	10090
32872333	667	681	streptozotocin	Chemical	MESH:D013311
32872333	683	686	STZ	Chemical	MESH:D013311
32872333	698	706	diabetes	Disease	MESH:D003920
32872333	714	717	STZ	Chemical	MESH:D013311
32872333	752	763	pemafibrate	Chemical	MESH:C540740
32872333	777	780	STZ	Chemical	MESH:D013311
32872333	789	797	diabetic	Disease	MESH:D003920
32872333	798	802	mice	Species	10090
32872333	863	876	blood glucose	Chemical	MESH:D001786
32872333	1072	1083	pemafibrate	Chemical	MESH:C540740
32872333	1100	1113	blood glucose	Chemical	MESH:D001786
32872333	1131	1136	lipid	Chemical	MESH:D008055
32872333	1189	1215	fibroblast growth factor21	Gene	56636
32872333	1232	1250	retinal functional	Disease	MESH:D012173
32872333	1283	1296	synaptophysin	Gene	20977
32872333	1319	1322	STZ	Chemical	MESH:D013311
32872333	1331	1339	diabetic	Disease	MESH:D003920
32872333	1340	1344	mice	Species	10090
32872333	1383	1394	pemafibrate	Chemical	MESH:C540740
32872333	1431	1433	DR	Disease	MESH:D003930
32872333	Positive_Correlation	MESH:D013311	MESH:D003920
32872333	Negative_Correlation	MESH:C540740	MESH:D012173
32872333	Positive_Correlation	MESH:C540740	20977
32872333	Positive_Correlation	MESH:C540740	56636
32872333	Negative_Correlation	MESH:C540740	MESH:D015228
32872333	Association	MESH:C540740	MESH:D008055
32872333	Negative_Correlation	MESH:C540740	MESH:D012164
32872333	Association	MESH:C540740	19013
32872333	Negative_Correlation	MESH:C540740	MESH:D001786
32872333	Negative_Correlation	MESH:C540740	MESH:D003930

